placulumab (CEP-37247) / Teva 
Welcome,         Profile    Billing    Logout  
 13 Diseases   1 Trial   1 Trial   2 News 
1 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
placulumab (CEP-37247) / Teva
ACTRN12607000275460: A Phase I, Single Ascending Dose, Safety and Pharmacokinetic Study of PN0621 in Healthy Volunteers

Recruiting
1
30
 
Peptech Limited, Peptech Limited
Inflammatory dieseases, Healthy Volunteers
 
 

Download Options